Cetirizine

WikiDoc Resources for Cetirizine
Articles
Most recent articles on Cetirizine Most cited articles on Cetirizine Review articles on Cetirizine Articles on Cetirizine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cetirizine Images of Cetirizine Photos of Cetirizine Podcasts & MP3s on Cetirizine Videos on Cetirizine
Evidence Based Medicine
Cochrane Collaboration on Cetirizine Bandolier on Cetirizine TRIP on Cetirizine
Clinical Trials
Ongoing Trials on Cetirizine at Clinical Trials.gov Trial results on Cetirizine Clinical Trials on Cetirizine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cetirizine NICE Guidance on Cetirizine NHS PRODIGY Guidance FDA on Cetirizine CDC on Cetirizine
Books
Books on Cetirizine
News
Cetirizine in the news Be alerted to news on Cetirizine News trends on Cetirizine
Commentary
Blogs on Cetirizine
Definitions
Definitions of Cetirizine
Patient Resources / Community
Patient resources on Cetirizine Discussion groups on Cetirizine Patient Handouts on Cetirizine Directions to Hospitals Treating Cetirizine Risk calculators and risk factors for Cetirizine
Healthcare Provider Resources
Symptoms of Cetirizine Causes & Risk Factors for Cetirizine Diagnostic studies for Cetirizine Treatment of Cetirizine
Continuing Medical Education (CME)
CME Programs on Cetirizine
International
Cetirizine en Espanol Cetirizine en Francais
Business
Cetirizine in the Marketplace Patents on Cetirizine
Experimental / Informatics
List of terms related to Cetirizine

Synonyms / Brand Names:

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Dosing and Administration

Adults and Children 12 Years of Age and Older: The recommended dose of ZYRTEC-D 12 HOUR™ Extended Release Tablets is one tablet twice daily for adults and children 12 years of age and older.

Dose Adjustment for Renal and Hepatic Impairment: In patients with decreased renal function(creatinine clearance 11-31 mL/min), patients on hemodialysis (creatinine clearance less than 7 mL/min), and in hepatically impaired patients, a dose of one tablet once daily is recommended.

ZYRTEC-D 12 HOUR™ Extended Release Tablets may be given with or without food and should be swallowed whole, avoiding breaking or chewing the tablet.

Adapted from the FDA Package Insert.